21 results
8-K
EX-2.1
SEEL
Seelos Therapeutics Inc
19 Feb 19
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
8:00am
8-K
EX-2.1
SEEL
Seelos Therapeutics Inc
16 Jan 19
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
SEEL
Seelos Therapeutics Inc
16 Jan 19
Business combination disclosure
12:00am
8-K
EX-2.1
SEEL
Seelos Therapeutics Inc
14 Dec 18
Entry into a Material Definitive Agreement
4:48pm
425
EX-2.1
SEEL
Seelos Therapeutics Inc
14 Dec 18
Business combination disclosure
4:46pm
8-K
EX-2.1
m9ivx9ks
16 Oct 18
Entry into a Material Definitive Agreement
8:57pm
425
EX-2.1
4bi 5hfxv
16 Oct 18
Business combination disclosure
8:56pm
8-K
EX-2.1
reww1lfei91wasxlk
20 Sep 18
Entry into a Material Definitive Agreement
9:43pm
425
EX-2.1
1uzd5qd5m4yowic5
30 Jul 18
Business combination disclosure
12:00am
425
EX-2.3
rlmfkuzae
30 Jul 18
Business combination disclosure
12:00am
8-K
EX-2.2
vc5prcw
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.3
01odo
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
ubyg 4q0uwixiry
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
425
EX-2.2
visvjd
30 Jul 18
Business combination disclosure
12:00am
SC 13D
EX-2
qnamst xu9r
23 Feb 15
Beneficial ownership report
12:00am
8-K
EX-2.1
a1uf5wwymhi9xe
1 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
n2lhijbo5 rg5wo6kq
13 Jul 12
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-2.1
o0peerh0
6 Jul 11
Completion of Acquisition or Disposition of Assets
12:00am